INDIANAPOLIS – Pharmaceutical behemoth Eli Lilly announced a groundbreaking new initiative today designed to help corporations manage rising healthcare costs by, paradoxically, making it easier for them to cover expensive weight-loss drugs. The program, dubbed 'The Perpetual Profit Partnership,' connects employers directly with third-party administrators specializing in obesity treatment benefits, ensuring a seamless pipeline from employee wellness programs to Lilly’s bottom line.

“We understand that navigating the complex world of employee health benefits can be daunting,” stated Dr. Brenda Carmichael, Head of Strategic Market Expansion for Lilly’s Metabolic Health division, in a press release. “Our goal is to remove every barrier between a concerned employer and a comprehensive, long-term commitment to managing their workforce’s expanding waistlines with our cutting-edge solutions.”

Critics immediately hailed the program as a masterstroke in circular economics. “It’s brilliant, really,” commented financial analyst Marcus Thorne. “First, you create the conditions for a sedentary, high-sugar lifestyle. Then, you offer the ‘cure’ and make it incredibly simple for the very entities responsible for those conditions – employers – to pay for it. It’s like a snake eating its own tail, but the snake is wearing a lab coat and charging a premium.”

Company insiders suggest the next phase of the program will involve partnering with fast-food chains to offer discounted meal plans, further solidifying the 'health-to-medicine' pipeline.